|
John C. Weiss III currently serves as Chairman and CEO of Claragen Inc. a development-stage biopharmaceutical company. He has served in that capacity since April 2004. He also serves as Assistant Professor of Finance at University of Baltimore. He was formerly the Executive Director of the Entrepreneurship Program at the Robert G. Merrick School of Business University of Baltimore from 1999 to 2004. He also formerly served as Executive in Residence for the Office of Research and Development at the University of Maryland Baltimore from July 2002 thru June 2004. Since 1990 Mr. Weiss has served on the board of trustees of the St. Agnes Healthcare Foundation in Baltimore Maryland. Since 1995 he has served on the board of visitors of the University of Maryland Baltimore and also served on the board of visitors of Towson University from 1995 to 2004. Mr. Weiss has formerly served in the capacity as either director or partner of several venture capital firms namely the Maryland Venture Capital Trust from 1990 to 2002 Anthem Capital L.P. from 1992 to 1996 and Arete Ventures Inc. from 1984 to 1990. From 2000 to 2002 Mr. Weiss served as interim Executive Director of the Baltimore City Parking Authority Inc. Mr. Weiss formerly served on the board of directors of Chesapeake Biological Laboratories Inc. (NASDAQ: CBLI) Baltimore Maryland from 1986 to 1998 and was its president from 1996 to 1998. Mr. Weiss is also an active member of several other community and civic boards in the Baltimore area. Mr. Weiss has a Master of Business Administration degree from Loyola College Baltimore Maryland. | 